Use In General Anesthesia For Surgery Therapeutics
1. Raplon patent expiration
Treatment: NA
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5418226 | ORGANON USA INC | Monoquaternary 2,16-bispiperidinylandrostane derivatives |
Apr, 2013
(12 years ago) | |
Drugs and Companies using RAPACURONIUM BROMIDE ingredient
Market Authorisation Date: 18 August, 1999
Dosage: INJECTABLE
More Information on Dosage
RAPLON family patents
